RecruitingNCT07584577
Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer
Sponsor
University Hospital, Bordeaux
Enrollment
670 participants
Start Date
Nov 1, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patient undergoing surgery for esophageal cancer
- Malnourished patient at the time of management
- Receiving neoadjuvant treatment
Exclusion Criteria2
- Patient not malnourished at the time of management
- Patient who did not receive neoadjuvant treatment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTEnteral or parenteral nutrition
Patients who did not receive enteral or parenteral nutrition during neoadjuvant treatment.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07584577
Related Trials
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
NCT061816561 location
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
NCT071625061 location
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
NCT070386291 location
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT0646506933 locations
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
NCT064149021 location